Delivery Order SPE2DR25D3504-SPE2DR26F7CX2
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $89,553.56 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count packages) on January 30, 2026, with an ultimate completion date of February 2, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical supplier to federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $58,252.86 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 MG tablets (8-count units) under a firm fixed price contract. The order, issued on August 14, 2025, with an ultimate completion date of August 15, 2025, represents a non-competitive delivery against an existing contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $10,676.74 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count packages) on January 16, 2026, with completion targeted for January 20, 2026. This firm fixed-price, competitively awarded contract (no set-aside) is being performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider,...
- The Defense Logistics Agency awarded a delivery order valued at $1,499.28 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count) with an ultimate completion date of October 20, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a single transaction under AmerisourceBergen's larger pharmaceutical supply contract vehicle with DLA. The product will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,655.81 to Amerisourcebergen Drug Corp for the supply of NURTEC ODT 75 MG tablets (8-count) on January 27, 2026. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is located in Conshohocken, Pennsylvania, where Amerisourcebergen maintains its corporate headquarters. This delivery order will be completed by January 28, 2026. This...
- The Defense Logistics Agency awarded a delivery order valued at $10,522.29 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 MG tablets (quantity 8 units) on January 15, 2026, with an ultimate completion date of January 16, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation. The contract will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent...
- The Defense Logistics Agency awarded a Delivery Order valued at $8,406.33 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 MG tablets (8-count packaging). This competitively awarded, firm fixed-price contract was issued on November 13, 2025, with an ultimate completion date of November 14, 2025. The contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,404.62 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count units). This firm fixed-price, competitively awarded delivery order was issued on September 8, 2025, with an ultimate completion date of September 9, 2025. The pharmaceutical products will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $7,956.18 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8 count) on January 6, 2026, with completion scheduled for January 7, 2026. This firm fixed-price, competitively awarded delivery order is being performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was competed on a full and open basis among qualified...
- The Defense Logistics Agency awarded a delivery order valued at approximately $14K to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 MG tablets (8-count units) on January 26, 2026, with completion scheduled for January 27, 2026. This is a firm fixed-price, non-set-aside contract performed at the awardee's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal medical...
- SPE2DR25D3504Indefinite Delivery Contract
- SPE2DR25D3504-SPE2DR26F7CX2Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,442.62 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count units) on February 2, 2026, with an ultimate completion date of February 3, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor and critical vendor for federal medical procurement. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems. The IDC enables the contractor to supply an extensive range of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 2/1/26 |